All News

The US Food and Drug Administration has approved Allergan's supplemental New Drug Application to expand the approved use of their cephalosporin / beta-lactamase inhibitor combo antibiotic, AVYCAZ (ceftazidime and avibactam), to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the following susceptible Gram-negative microorganisms: Klebsiella pneumoniae, Enterobacter cloacae, Escherichia coli, Serratia marcescens, Proteus mirabilis, Pseudomonas aeruginosa, and Haemophilus influenzae in patients 18 years of age or older.

Natural Cycles is a EU-cleared application to help women avoid pregnancy, but recently there have been some concerns about how well it works.

Feeling down this winter? Check out easy ways to boost your mood naturally.

This year’s flu season is on track to exceed previous seasons of high severity in hospitalization rates as influenza activity and related deaths continue to climb across the United States, according to a CDC media briefing held today.

Could giving patients money help improve their adherence? Mount Sinai is currently piloting a new platform to find out.

New Amazon health care venture may lead to more effective specialty drug management.

HIV test can distinguish the prevalence of antibodies corresponding with a new or established infection.

Rilipivirine exposure was up to 40% lower among pregnant patients with HIV.

A look at last week's top stories in the world of pharmacy.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

Obeticholic acid was incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, according to the FDA.

Diabetes treatment guidelines treating patients until they reach blood pressure target goals.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Officials with the FDA have added a boxed warning label to liver disease medicine obeticholic acid (Ocaliva, Intercept) to highlight the correct dosing for patients with rare chronic liver disease, according to a FDA safety announcement.

The NCPA stated that this underpayment leaves pharmacies in jeopardy as they continue to dispense the flu medication.

Prescription drug costs projected to increase 7.35% for health systems in 2018.

Newly-discovered gene mutations could double the risk of breast cancer.

Access to Tamiflu and generic oseltamivir are critical for combatting rampant influenza infections.

A single blood test could diagnose 8 different types of cancer simultaneously.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

From time to time, localities experience outbreaks of vaccine-preventable diseases and need to engage emergency teams to assist in vaccination efforts.

Actual target blood pressures differ between guidelines.

The CDC finds people between the ages of 15 to 44 are significantly more likely to have never been tested for HIV.

Patients who undergo lung resection surgery found to become persistent opioid users in the months following their procedure.

It is important for patients to have accurate and reputable drug information resources at their disposal.

January is Thyroid Disorder Awareness Month, but the role of the pharmacist in managing this disorder can benefit the patient throughout the year.

Helping patients choose the best probiotics for their needs: an update